Health technology assessment (HTA) is a formidable task across drug development, medical device innovation, and digital health solutions. To help with this task, the European HTA Regulation entered into force in January 2022 and will apply…
Continue Reading
What You Should Know; – Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., a dedicated subsidiary focused on developing and commercializing innovative BioChips – advanced microfluidic platforms that mimic human…
Continue Reading
What You Should Know:
– ARC Innovation, the innovation arm of Sheba Medical Center, Israel’s leading medical center and a six-time Newsweek World’s Best Hospital awardee, today announced its participation in the Trustworthy & Responsible…
Continue Reading
What You Should Know:
– BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for new uses, today announced a strategic partnership to revolutionize drug…
Continue Reading
What You Should Know:
– Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.
– The…
Continue Reading
What You Should Know:
– Deciphex, a leading digital pathology company based in Dublin, Ireland, has announced a collaborative effort with Novartis, a prominent multinational pharmaceutical corporation.
– The strategic partnership focuses on developing innovative artificial…
Continue Reading
Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific…
Continue Reading
In this episode, Pilar Fernandez Hermida – International Go-To-Market Expert with 20+ years of experience launching sales & partner ecosystem strategies, talks about: The potential of the Middle East and MENA region for healthtech…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
